EUR 0.12
(1.65%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4.31 Million EUR | -22.98% |
2022 | 5.59 Million EUR | 27.11% |
2021 | 4.4 Million EUR | -9.2% |
2020 | 4.85 Million EUR | -28.95% |
2019 | 6.82 Million EUR | -9.85% |
2018 | 7.57 Million EUR | -7.32% |
2017 | 8.17 Million EUR | 9.53% |
2016 | 7.46 Million EUR | 19.82% |
2015 | 6.22 Million EUR | 42.82% |
2014 | 4.36 Million EUR | -5.51% |
2013 | 4.61 Million EUR | 19.04% |
2012 | 3.87 Million EUR | 29.08% |
2011 | 3 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 2.44 Million EUR | 0.0% |
2023 Q4 | 2.07 Million EUR | 0.0% |
2023 FY | 4.31 Million EUR | -22.98% |
2023 Q2 | 2.23 Million EUR | 0.0% |
2022 Q2 | 2.54 Million EUR | 0.0% |
2022 Q4 | 3.05 Million EUR | 0.0% |
2022 FY | 5.59 Million EUR | 27.11% |
2021 Q2 | 2.22 Million EUR | 0.0% |
2021 FY | 4.4 Million EUR | -9.2% |
2021 Q4 | 2.17 Million EUR | 0.0% |
2020 Q2 | 2.27 Million EUR | 0.0% |
2020 FY | 4.85 Million EUR | -28.95% |
2020 Q4 | 2.57 Million EUR | 0.0% |
2019 Q2 | 3.44 Million EUR | 0.0% |
2019 FY | 6.82 Million EUR | -9.85% |
2019 Q4 | 3.38 Million EUR | 0.0% |
2018 FY | 7.57 Million EUR | -7.32% |
2018 Q2 | 3.62 Million EUR | 0.0% |
2018 Q4 | 3.94 Million EUR | 0.0% |
2017 FY | 8.17 Million EUR | 9.53% |
2017 Q2 | 4.19 Million EUR | 0.0% |
2017 Q4 | 3.97 Million EUR | 0.0% |
2016 FY | 7.46 Million EUR | 19.82% |
2016 Q2 | 3.63 Million EUR | 0.0% |
2016 Q4 | 3.83 Million EUR | 0.0% |
2015 Q4 | 3.25 Million EUR | 0.0% |
2015 Q2 | 2.96 Million EUR | 0.0% |
2015 FY | 6.22 Million EUR | 42.82% |
2014 Q4 | 2.25 Million EUR | 0.0% |
2014 Q2 | 2.1 Million EUR | 0.0% |
2014 FY | 4.36 Million EUR | -5.51% |
2013 Q4 | 2.29 Million EUR | 0.0% |
2013 FY | 4.61 Million EUR | 19.04% |
2013 Q2 | 2.31 Million EUR | 0.0% |
2012 Q1 | 969.25 Thousand EUR | 0.0% |
2012 Q2 | 969.25 Thousand EUR | 0.0% |
2012 Q3 | 969.25 Thousand EUR | 0.0% |
2012 FY | 3.87 Million EUR | 29.08% |
2012 Q4 | 1.13 Million EUR | 17.01% |
2011 Q2 | 750.89 Thousand EUR | 0.0% |
2011 Q1 | 750.89 Thousand EUR | 0.0% |
2011 Q3 | 750.89 Thousand EUR | 0.0% |
2011 Q4 | 969.25 Thousand EUR | 29.08% |
2011 FY | 3 Million EUR | 0.0% |
2010 Q4 | 750.89 Thousand EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Affluent Medical SA | 1.22 Million EUR | -252.353% |
Bluelinea Société Anonyme | 9826.00 EUR | -43791.696% |
Carmat SA | 2.84 Million EUR | -51.433% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | 89.769% |
Euromedis Groupe | 37.42 Million EUR | 88.477% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | 96.699% |
Ikonisys S.A. | 448.55 Thousand EUR | -861.483% |
Implanet S.A. | 7.44 Million EUR | 42.087% |
Median Technologies SA | 22.22 Million EUR | 80.596% |
Theraclion SA | 1.82 Million EUR | -136.678% |
Euroapi S.A. | 1.01 Billion EUR | 99.577% |
Guerbet SA | 785.69 Million EUR | 99.451% |